Avricore Health (AVCRF) Return on Sales (2015 - 2025)

Avricore Health (AVCRF) has 11 years of Return on Sales data on file, last reported at 0.1% in Q3 2025.

• Return on Sales for Q3 2025 came in at 0.1%, down 10.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.03%, down 3.0% from the prior year.
• Return on Sales improved to 0.1% in Q3 2025 per AVCRF's latest filing, from 0.16% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q1 2023 and troughed at 0.16% in Q2 2025.
• A 5-year average of 0.03% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2021 and 2025: Return on Sales soared 36 bps in 2021, then decreased 16 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then surged by 79 bps to 0.0% in 2022, then soared by 121 bps to 0.0% in 2023, then tumbled by 388 bps to 0.0% in 2024, then plunged by 6679 bps to 0.1% in 2025.
• Business Quant data shows AVCRF's Return on Sales at 0.1% in Q3 2025, 0.16% in Q2 2025, and 0.0% in Q1 2025.